Login
Password
Remember Me
TreeFrog Therapeutics secures €30 million from EIB TreeFrog Therapeutics, a French biotech specializing in cell therapy, has secured a €30 million...
CellProthera Selects CELLforCURE by SEQENS for Phase 3 GMP Manufacturing of its stem cell-based therapy First clinical batches of ProtheraCytes® are planned...
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies CRISPR Therapeutics, a Swiss biopharmaceutical company focused on...
More articles from NEWS
True cost of sickle cell disease: $1.5 billion in lost productivity per year Sickle cell disease causes $1.5 billion in lost...
Record financing for the regenerative medicine sector through Q3 2020 The regenerative medicine sector attracted $15.9 billion in financing through just...
How to increase the number of European-based ATMP clinical trials? The latest report published by the Alliance for Regenerative Medicine (ARM),...
More articles from ANALYSES
First vascularized model of stem cell islet cells Researchers led by Maike Sander, Scientific Director of the Max Delbrück Center, have...
Why are patients with mitochondrial disease more susceptible to infections? The cell at the top right is dying through caspase-11 dependent...
GNT0004 product confirms its clinical efficacy with stabilization of motor functions in patients treated at the effective dose for up to...
More articles from SCIENTIFIC NEWS